Telbivudine vs tenofovir in hepatitis B e antigen-negative chronic hepatitis B patients: OPTIMA roadmap study

AIM: To make efficacy and safety comparison of telbivudine-raodmap and tenofovir-roadmap in hepatitis B e antigen (HBeAg)-negative chronic hepatitis B (CHB) patients. METHODS: This was the first prospective, randomised, two-arm, open-label, non-inferiority study in HBeAg-negative CHB patients that c...

Descripción completa

Detalles Bibliográficos
Autores principales: Krastev, Zahari, Petrova, Diana, Kotzev, Iskren, Celen, Mustafa Kemal, Mendelson, Meryl, Chandra, Richa, Pandey, Priti, Hamed, Kamal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2016
Materias:
Randomized Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5114476/
https://www.ncbi.nlm.nih.gov/pubmed/27917266
http://dx.doi.org/10.4254/wjh.v8.i32.1402

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5114476/
https://www.ncbi.nlm.nih.gov/pubmed/27917266
http://dx.doi.org/10.4254/wjh.v8.i32.1402

Ejemplares similares